Use of atracurium in a patient susceptible to malignant hyperthermia.
D000769:Anesthesia, Inhalation; D001279:Atracurium; D002648:Child; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage*; D008305:Malignant Hyperthermia / Q000139:chemically induced; D009127:Muscle Rigidity / Q000139:chemically induced; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage*; D013390:Succinylcholine / Q000009:adverse effects*
D007546:Isoquinolines; D009466:Neuromuscular Blocking Agents; D001279:Atracurium; D013390:Succinylcholine